Suppr超能文献

阿立哌唑持续治疗对多巴胺超敏的精神分裂症患者复发性精神病性发作严重程度的降低作用:一例报告

Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report.

作者信息

Tadokoro Shigenori, Nonomura Naho, Kanahara Nobuhisa, Hashimoto Kenji, Iyo Masaomi

机构信息

Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan.

Health Administration Center, Muroran Institute of Technology, Hokkaido, Japan.

出版信息

Clin Psychopharmacol Neurosci. 2017 Feb 28;15(1):79-81. doi: 10.9758/cpn.2017.15.1.79.

Abstract

Dopamine supersensitivity psychosis (DSP) is a type of acute exacerbation of recurrent psychosis caused by long-term treatment with antipsychotics in schizophrenic patients. Although DSP is exceedingly troublesome for clinicians, effective treatment has not yet been established. Based on clinical research and our animal study, we hypothesize that aripiprazole, an atypical antipsychotic, may reduce the exacerbation of recurrent psychotic episodes. We report the case of a 46-year-old female who suffered from schizophrenia with DSP. In this case, sustained treatment with a high dose of aripiprazole gradually reduced the  severity of her recurrent psychotic episodes. In conclusion, sustained treatment with aripiprazole may reduce the exacerbation of recurrent psychotic episodes in schizophrenic patients with DSP, and may be an effective treatment of DSP.

摘要

多巴胺超敏性精神病(DSP)是精神分裂症患者长期使用抗精神病药物治疗引起的复发性精神病的一种急性加重类型。尽管DSP给临床医生带来极大困扰,但尚未确立有效的治疗方法。基于临床研究和我们的动物研究,我们推测非典型抗精神病药物阿立哌唑可能会减轻复发性精神病发作的加重情况。我们报告了一例患有DSP的46岁女性精神分裂症患者的病例。在该病例中,高剂量阿立哌唑持续治疗逐渐减轻了她复发性精神病发作的严重程度。总之,阿立哌唑持续治疗可能会减轻患有DSP的精神分裂症患者复发性精神病发作的加重情况,可能是治疗DSP的一种有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9507/5290712/a91144b64282/cpn-15-079f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验